Please use this identifier to cite or link to this item: https://repository.monashhealth.org/monashhealthjspui/handle/1/29396
Title: Current aspects of TIA management.
Authors: Srikanth V.;Ma H. ;Singhal S.;Ly J.;Phan T.G.;Clissold B.
Monash Health Department(s): Neurology
Institution: (Clissold, Phan, Ly, Singhal, Srikanth, Ma) Stroke Unit, Department of Neurosciences, Monash Medical Centre and Stroke and Aging Research Group, Department of Medicine, Monash University, Australia
Issue Date: 17-Feb-2020
Copyright year: 2020
Publisher: Churchill Livingstone
Place of publication: United Kingdom
Publication information: Journal of Clinical Neuroscience. 72 (pp 20-25), 2020. Date of Publication: February 2020.
Journal: Journal of Clinical Neuroscience
Abstract: Transient Ischaemic Attack (TIA) if untreated carries a high risk of early stroke and is associated with poorer long-term survival [1]. There is emerging evidence of a reduction in stroke risk following TIA. Time critical investigations and management, as well as service organisation remain key to achieving good outcomes. Patients are diagnosed with TIA if they have transient, sudden-onset focal neurological symptoms which usually completely and rapidly resolve by presentation. The tissue based definition of TIA guides the fact that patients with residual symptoms should be considered as potentially having a stroke, with urgent evaluation regarding eligibility for thrombolysis and/or endovascular clot retrieval (ECR). Essential investigations for all patients with TIA should include early brain imaging, ECG, and carotid imaging in patients with anterior circulation symptoms. After brain imaging, exclusion of high risk indicators and immediate administration of an antiplatelet agent, subsequent attention to other mechanistic factors can be managed safely as part of a structured clinical pathway supervised by stroke specialists. This is in line with the recently revised Stroke Foundation Clinical Guidelines for Stroke Management (2017).Copyright © 2019 Elsevier Ltd
DOI: http://monash.idm.oclc.org/login?url=http://dx.doi.org/10.1016/j.jocn.2019.12.032
PubMed URL: 31911111 [http://www.ncbi.nlm.nih.gov/pubmed/?term=31911111]
ISSN: 0967-5868
URI: https://repository.monashhealth.org/monashhealthjspui/handle/1/29396
Type: Review
Subjects: risk factor
*transient ischemic attack/dt [Drug Therapy]
*transient ischemic attack/th [Therapy]
acetylsalicylic acid/dt [Drug Therapy]
antithrombocytic agent/dt [Drug Therapy]
atorvastatin/dt [Drug Therapy]
clopidogrel/dt [Drug Therapy]
glucose/ec [Endogenous Compound]
medical specialist
blood clot lysis
brain radiography
cerebrovascular accident/dt [Drug Therapy]
clinical assessment tool
clinical feature
electrocardiogram
glucose blood level
health service
high risk population
hospital admission
human
lifestyle modification
neuroimaging
outpatient care
practice guideline
priority journal
prognosis
review
transient ischemic attack
acetylsalicylic acid
antithrombocytic agent
atorvastatin
clopidogrel
glucose
medical specialist
blood clot lysis
brain radiography
cerebrovascular accident
tool
electrocardiogram
glucose blood level
health service
high risk
hospital admission
lifestyle modification
neuroimaging
outpatient care
practice guideline
human
lifestyle modification
medical specialist
neuroimaging
outpatient care
practice guideline
priority journal
prognosis
brain radiography
risk factor
*transient ischemic attack / *drug therapy / *therapy
blood clot lysis
Review
cerebrovascular accident / drug therapy
clinical assessment tool
clinical feature
electrocardiogram
glucose blood level
health service
high risk population
hospital admission
Type of Clinical Study or Trial: Review article (e.g. literature review, narrative review)
Appears in Collections:Articles

Show full item record

Page view(s)

14
checked on Aug 16, 2024

Google ScholarTM

Check


Items in Monash Health Research Repository are protected by copyright, with all rights reserved, unless otherwise indicated.